Device Trial Radar · NCT03804060
REperfusion With Cooling in CerebraL Acute IscheMia II
Last checked: Nov 20, 2026Latest source record: May 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
90
Actual
Start
May 23, 2019
Primary completion
May 1, 2024
Study completion May 1, 2024
Sponsor
- Lead sponsor
- ZOLL Circulation, Inc., USANot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 15, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to determine the feasibility and safety of achieving rapid hypothermia with the Proteus Intravascular Temperature Management (IVTM) system for patients experiencing acute ischemic stroke due to a large vessel occlusion.
Conditions
- Ischemic Stroke
Interventions
Thermogard XP3Device
Cooling with the ZOLL® Circulation catheter and the ZOLL® Intravascular Temperature Management system to initiate and maintain hypothermia for 6 hours as an adjunct to endovascular Recanalization.
Recanalization onlyProcedure
Standard of Care for recanalization
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Test Arm patients achieving target temperatureTime frame: 1 hour after thrombectomy
- Mean door-to-Recanalization timeTime frame: perioperative
- Rate of hemorrhagic conversion in each arm within 36 hours of RecanalizationTime frame: 36 hours
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
WellStar Kennestone Regional Medical Center
Marietta, Georgia
The Queen's Medical Center
Honolulu, Hawaii
University of Chicago Medical Center
Chicago, Illinois
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.